Physician profile
John L Glomset
NPI 1043400641
$46,932.44
in general payments reported to CMS, 2019-2025
17 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,604 · 2020: $2,168 · 2021: $1,934 · 2022: $3,639 · 2023: $4,850 · 2024: $19K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,663 · Travel and Lodging: $4,998 · Food and Beverage: $3,236 · Education: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,662.50 |
| Travel and Lodging | $4,998.07 |
| Food and Beverage | $3,235.66 |
| Education | $565.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $26,106.65 | 2019-2025 | Tornier Perform Reversed Augmented Glenoid, Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Smith+Nephew, INC. | $12,261.94 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Trigen Intertan |
| Pylant Medical | $6,996.16 | 2019-2022 | |
| Arthrex, INC. | $623.52 | 2019-2023 | Shoulder Implants Fibertak Knotless |
| Trice Medical, INC. | $262.13 | 2020-2022 | |
| Anika Therapeutics, INC. | $168.32 | 2022-2025 | Integrity Implant |
| Nalu Medical, INC. | $153.19 | 2025 | Nalu Neurostimulation System |
| Vericel Corporation | $90.47 | 2021-2024 | Maci |
| Depuy Synthes Sales INC. | $88.18 | 2020-2025 | Truespan Orthocord, Na, Lcp |
| Orthofix Medical, INC. | $50.73 | 2020-2021 | |
| Linvatec Corporation | $28.96 | 2023 | Biobrace 23mm |
| Acera Surgical, INC. | $23.62 | 2025 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $20.37 | 2025 | Zynrelef |
| P Bar Medical LLC | $19.55 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $14.92 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $12.12 | 2020 | |
| Pacira Therapeutics, INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Glomset listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.